However, contradictory results were observed in some other cancer types, such as gastric and prostate cancer, which indicated that PRKAA2 was a protective gene in cancer development by upregulating the expression of hypoxia-inducible factor-1α and hepatocyte nuclear factor 4α [37, 38]. The gene discussed is PRKAA2; the disease is prostate cancer.